Trial therapy could ‘turbocharge’ sick kids’ immune cells

The two-year study of up to 20 children as young as three months old will test whether giving them immunotherapy after their transplant reduces the risk of dangerous viral infections.Two patients at the Queensland Children’s Hospital have already received the treatment manufactured at the QIMR Berghofer Medical Research Institute.Scientist Rajiv Khanna, who developed the immunotherapy, said the research targeted children with blood cancer or genetic immune deficiencies who had received stem cells…



Click here to view the original article.